✦ LIBER ✦

Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma

✍ Scribed by Marc C. Chamberlain; Denice D. Tsao-Wei; Susan Groshen

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 101 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21582

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage chemotherapy with CPT-11 for rec

Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic astrocytoma

✍ Marc C. Chamberlain; Denice D. Wei-Tsao; Deborah T. Blumenthal; Michael J. Glant 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract ## BACKGROUND. The primary objective of this prospective phase 2 study of CPT‐11 in adult patients with recurrent temozolomide‐refractory anaplastic astrocytoma (AA) was to evaluate 6‐month progression‐free survival (PFS). ## METHODS. Forty patients (27 men and 13 women) ages 17 to 5

Salvage chemotherapy with cyclophosphami

Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme

✍ Marc C. Chamberlain; Denice D. Tsao-Wei 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Abstract ## BACKGROUND The primary objective of the current prospective Phase II study of cyclophosphamide (CYC) in adult patients with recurrent, temozolomide‐refractory glioblastoma multiforme was to evaluate 6‐month progression‐free survival (PFS). ## METHODS Forty patients (28 men and 12